Philips Korea and HoneyNaps Sign Sleep and Cardiovascular Health MOU

August 28, 2026
Philips Korea and HoneyNaps signed an MOU to explore healthcare projects that connect sleep disorder data with cardiovascular risk factors.
Philips Korea and HoneyNaps Sign Sleep and Cardiovascular Health MOU

Philips Korea, part of Royal Philips, and HoneyNaps signed a memorandum of understanding on August 19 to explore healthcare opportunities linking sleep disorders and cardiovascular health, the companies announced in a press release.

The partnership will focus on integrating sleep data with cardiovascular risk factors. The companies also plan to examine possible work in cardiology and other cardiovascular disease areas.

Philips Korea brings sleep and respiratory care products, healthcare provider networks, and commercial capabilities. HoneyNaps provides AI powered sleep medicine tools, including FDA authorized technology for sleep disorder diagnosis and analysis.

The companies said the collaboration may also include academic initiatives related to sleep and cardiovascular health.

We hope you enjoyed this article.

Subscribe to Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more